Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma

Published:2016-08 Issue:2 Volume:65 Page:289-295
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Abou-Alfa Ghassan K.,Puig Oscar,Daniele Bruno,Kudo Masatoshi,Merle Philippe,Park Joong-Won,Ross Paul,Peron Jean-Marie,Ebert Oliver,Chan Stephen,Poon Tung Ping,Colombo Massimo,Okusaka Takuji,Ryoo Baek-Yeol,Minguez Beatriz,Tanaka Takayoshi,Ohtomo Toshihiko,Ukrainskyj Stacey,Boisserie Frederic,Rutman Olga,Chen Ya-Chi,Xu Chao,Shochat Eliezer,Jukofsky Lori,Reis Bernhard,Chen Gong,Di Laurenzio Laura,Lee Ray,Yen Chia-Jui

Publisher

Elsevier BV

Subject

Hepatology

Reference29 articles.

1. Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest;Farooq;Mol Cells,2003

2. Expression of OCI-5/glypican 3 during intestinal morphogenesis: regulation by cell shape in intestinal epithelial cells;Li;Exp Cell Res,1997

3. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma;Capurro;Gastroenterology,2003

4. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules;Libbrecht;Am J Surg Pathol,2006

5. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis;Llovet;Gastroenterology,2006

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma;Molecular Cancer;2024-09-06

2. GPC3-targeted CAR-M cells exhibit potent antitumor activity against hepatocellular carcinoma;Biochemistry and Biophysics Reports;2024-09

3. Advancements in second-line treatment research for hepatocellular carcinoma;Clinical and Translational Oncology;2024-08-20

4. Exploring Glypican-3 as a Molecular Target in Hepatocellular Carcinoma: Perspectives on Diagnosis and Precision Immunotherapy Strategies;Frontiers in Bioscience-Landmark;2024-07-24

5. Dual‐Targeted Engineered Bacterial Outer Membrane Vesicles for Hepatocellular Carcinoma Immunotherapy;Advanced Functional Materials;2024-07-16